Fertility on the Rise: A Hopeful Outlook for the Saudi IVF Fertility Market

Forecasts vary by how each source defines the market, but they consistently indicate upward momentum. One outlook projects the Saudi Arabia IVF market will grow from US$ 306.59 million in 2024 to US$ 522.39 million by 2033, driven by a 6.10% CAGR (2025 to 2033). A separate source focused on IVF and fertility treatment products projects growth from USD 4.9 billion in 2025 to USD 8.6 billion by 2031, at a CAGR of 9.8% (2025 to 2031). In parallel, a broader fertility market forecast projects Saudi Arabia’s fertility market will rise from USD 28.4 billion in 2025 to USD 51.9 billion by 2031, at a 10.5% CAGR. These figures reflect different scopes, but together they highlight accelerating investment and utilization across the pathway from diagnosis to lab-supported conception.

What Is Driving IVF Demand and Clinic Expansion in the Kingdom?

Sources repeatedly emphasize delayed parenthood as a key driver. As more individuals prioritize education, career development, and financial stability before starting families, reliance on ART rises as natural fertility declines—especially for women. Technology also features prominently. Innovations cited include embryo selection technologies, cryopreservation systems, improved culture media formulations, AI-assisted embryo monitoring systems, and increasing adoption of genetic testing. On the service side, IVF is described as fertilizing an egg with sperm outside the body in a lab, monitoring the embryo, and then transferring it to the uterus; related steps mentioned include hormone therapy, genetic testing, egg harvesting, and embryo freezing. Together, these advances aim to improve success rates and personalize care as clinics expand their ART infrastructure.

Healthcare investment and the push to develop medical tourism are also shaping the market narrative. Sources describe large-scale investments in hospitals, medical cities, and specialized centers that expand access to advanced fertility services and support Saudi Arabia’s ambition to become a regional destination for high-value specialties such as reproductive medicine. One specific development noted is that in September 2024, Burjeel Holdings PLC announced plans to introduce IVF services in Saudi Arabia through its Trust Fertility Clinic at Burjeel Medical City, integrating gynecology, fetal medicine, pediatric subspecialties, and IVF services under one roof, supported by advanced NICU and PICU facilities. Sources also mention government support and expanding insurance coverage as factors contributing to improved accessibility, alongside growing awareness and shifting cultural perceptions toward fertility treatments.

Constraints remain material, and sources describe them as both practical and cultural. High treatment costs are repeatedly cited as a major barrier, linked to sophisticated equipment, skilled personnel, and the need for multiple cycles; incremental insurance coverage is mentioned, but affordability remains challenging for many patients. Ethical concerns and uneven regulatory frameworks are also noted as limiting factors in parts of Saudi Arabia. In addition, cultural and religious considerations influence which techniques can be offered. Multiple sources state that certain assisted reproduction practices—such as surrogacy and third-party gamete donation—are generally not permitted under Islamic law. Within those boundaries, the outlook across sources still points to steady expansion and increasing mainstream acceptance, supported by continued education, policy support, and ongoing healthcare modernization.